P. Collis

956 total citations
12 papers, 788 citations indexed

About

P. Collis is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, P. Collis has authored 12 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in P. Collis's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Reconstructive Surgery and Microvascular Techniques (2 papers). P. Collis is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Reconstructive Surgery and Microvascular Techniques (2 papers). P. Collis collaborates with scholars based in United States, Italy and Germany. P. Collis's co-authors include Michael Antoniou, Dale Talbot, Miguel Vidal, David R. Greaves, Frank Grosveld, S. A. Danner, Cindy Christopherson, Remko van Leeuwen, Clive Loveday and Monique Nijhuis and has published in prestigious journals such as Nature, Journal of Allergy and Clinical Immunology and The Journal of Infectious Diseases.

In The Last Decade

P. Collis

8 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Collis United States 4 400 355 322 153 144 12 788
Anneleen Hombrouck Belgium 13 389 1.0× 356 1.0× 271 0.8× 66 0.4× 146 1.0× 19 642
Daniela Lener France 12 281 0.7× 349 1.0× 408 1.3× 12 0.1× 95 0.7× 18 602
Adrianne D. Gladden United States 9 198 0.5× 388 1.1× 309 1.0× 55 0.4× 155 1.1× 9 803
Giuliana Vallanti Italy 12 140 0.3× 228 0.6× 194 0.6× 143 0.9× 54 0.4× 20 463
Matthias Hamdorf Germany 8 73 0.2× 195 0.5× 253 0.8× 66 0.4× 103 0.7× 12 537
Xiugen Zhang United States 11 74 0.2× 76 0.2× 167 0.5× 33 0.2× 64 0.4× 12 407
Maritza Lienlaf United States 9 114 0.3× 289 0.8× 542 1.7× 28 0.2× 131 0.9× 17 836
H. Ralph United States 7 67 0.2× 118 0.3× 102 0.3× 56 0.4× 60 0.4× 10 313
Daniel Byrd United States 13 47 0.1× 127 0.4× 114 0.4× 90 0.6× 72 0.5× 20 440
Erica Giuliani Italy 12 46 0.1× 139 0.4× 125 0.4× 47 0.3× 54 0.4× 26 339

Countries citing papers authored by P. Collis

Since Specialization
Citations

This map shows the geographic impact of P. Collis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Collis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Collis more than expected).

Fields of papers citing papers by P. Collis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Collis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Collis. The network helps show where P. Collis may publish in the future.

Co-authorship network of co-authors of P. Collis

This figure shows the co-authorship network connecting the top 25 collaborators of P. Collis. A scholar is included among the top collaborators of P. Collis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Collis. P. Collis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wedner, H. James, Raffi Tachdjian, Timothy Craig, et al.. (2022). Sustained Reductions in Hereditary Angioedema (HAE) Attack Rates Observed over 96 Weeks of Oral Berotralstat Treatment Regardless of Initial Response. Journal of Allergy and Clinical Immunology. 149(2). AB164–AB164.
2.
Aygören‐Pürsün, Emel, et al.. (2022). Oral Berotralstat Treatment for 96 Weeks Consistently Reduces Hereditary Angioedema (HAE) Attack Rates Regardless of Baseline Attack Rate. Journal of Allergy and Clinical Immunology. 149(2). AB164–AB164. 1 indexed citations
3.
Gower, Richard, et al.. (2022). Sustained Improvement Observed in Patient-Reported Quality of Life (QoL) with 96 Weeks of Oral Berotralstat Treatment. Journal of Allergy and Clinical Immunology. 149(2). AB164–AB164. 1 indexed citations
4.
Johnston, Douglas, William R. Lumry, Aleena Banerji, et al.. (2020). Gastrointestinal (GI) Adverse Events (AEs) Observed With Berotralstat (BCX7353) Treatment for Hereditary Angioedema (HAE) are Primarily Mild, Self-limited, and Diminish with Time on Treatment. Journal of Allergy and Clinical Immunology. 145(2). AB102–AB102. 3 indexed citations
5.
Riedl, Marc A., William R. Lumry, Aleena Banerji, et al.. (2019). P154 SAFETY AND TOLERABILITY OF ONCE-DAILY ORAL KALLIKREIN INHIBITOR BCX7353 IN PHASE 3 APEX-2 HAE STUDY. Annals of Allergy Asthma & Immunology. 123(5). S28–S29. 3 indexed citations
6.
Zuraw, Bruce L., William R. Lumry, A. K. Banerji, et al.. (2019). P150 ORAL PROPHYLAXIS WITH BCX7353 REDUCES HAE ATTACK RATES AND IS WELL-TOLERATED: APEX-2 STUDY RESULTS. Annals of Allergy Asthma & Immunology. 123(5). S27–S27. 1 indexed citations
7.
Cornpropst, Melanie, P. Collis, Y.S. Babu, et al.. (2016). Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study. Allergy. 71(12). 1676–1683. 9 indexed citations
8.
Ison, Michael G., David S.C. Hui, Kate Clezy, et al.. (2012). A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized Adults. Antiviral Therapy. 18(5). 651–661. 51 indexed citations
9.
Chowdhry, Saeed, Ron Hazani, & P. Collis. (2010). 181B: ANATOMICAL LANDMARKS FOR SAFE ELEVATION OF THE DIEP FLAP: A CADAVERIC STUDY. Plastic & Reconstructive Surgery. 125(Supplement). 119–119.
10.
Chowdhry, Saeed, Ron Hazani, P. Collis, & Bradon J. Wilhelmi. (2010). Anatomical landmarks for safe elevation of the deep inferior epigastric perforator flap: a cadaveric study.. PubMed. 10. e41–e41. 3 indexed citations
11.
Schuurman, Rob, Monique Nijhuis, Remko van Leeuwen, et al.. (1995). Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC). The Journal of Infectious Diseases. 171(6). 1411–1419. 417 indexed citations
12.
Talbot, Dale, P. Collis, Michael Antoniou, et al.. (1989). A dominant control region from the human β-globin locus conferring integration site-independent gene expression. Nature. 338(6213). 352–355. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anneleen Hombrouck Breakdown of academic impact, for papers by Daniela Lener Breakdown of academic impact, for papers by Adrianne D. Gladden Breakdown of academic impact, for papers by Giuliana Vallanti Breakdown of academic impact, for papers by Matthias Hamdorf Breakdown of academic impact, for papers by Xiugen Zhang Breakdown of academic impact, for papers by Maritza Lienlaf Breakdown of academic impact, for papers by H. Ralph Breakdown of academic impact, for papers by Daniel Byrd Breakdown of academic impact, for papers by Erica Giuliani
Rankless by CCL
2026